![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Autoimmune Disorders |
|
Free Subscription
2 Am J Kidney Dis |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Autoimmune Disorders is free of charge.
Proliferative Glomerulonephritis With Monotypic Immunoglobulin Deposits of IgG1
Subclass: A Case Series.
Am J Kidney Dis. 2026 Nov 2:S0272-6386(26)01196.
PubMed
Abstract available
A Case of Bio-Dissimilarity: Rapidly Progressive Glomerulonephritis Following
Switch From Infliximab to Infliximab-abda.
Am J Kidney Dis. 2026 Oct 31:S0272-6386(26)01194.
PubMed
Abstract available
Real-world hospitalization and readmission trajectory after Guillain-Barre
syndrome in the United States.
BMC Neurol. 2026;26:702.
PubMed
Abstract available
Attitudes towards vaccination in multiple sclerosis: insights from patients,
neurologists, and general practitioners within a qualitative study.
BMC Neurol. 2026;26:697.
PubMed
Abstract available
Mitochondrial Haplogroup U and multiple sclerosis risk in Arab and Near Eastern
populations: a systematic review and meta-analysis.
BMC Neurol. 2026;26:685.
PubMed
Abstract available
Dysregulated CSF T-cell responses and their evolution after intravenous
immunoglobulin in Guillain-Barre syndrome.
Brain. 2026 Nov 5:awag379. doi: 10.1093.
PubMed
Abstract available
Multiple islet autoantibodies are associated with C-peptide below the reporting
limit and a limited fasting-to-120-minute increase in routine clinical testing.
Diabetes Res Clin Pract. 2026 Nov 5:113631. doi: 10.1016/j.diabres.2026.113631.
PubMed
Abstract available
Association between diabetes-related autoantibody positivity and renal impairment
in clinically diagnosed type 2 diabetes: a cross-sectional study.
Diabetes Res Clin Pract. 2026 Nov 3:113644. doi: 10.1016/j.diabres.2026.113644.
PubMed
Abstract available
VEXAS Syndrome with an Improvement of Chest Shadows without Immunosuppressive
Therapy.
Intern Med. 2026;65:2923-2928.
PubMed
Abstract available
Real-world Application of Subcutaneous Efgartigimod in Chronic Inflammatory
Demyelinating Polyradiculoneuropathy.
Intern Med. 2026;65:2912-2917.
PubMed
Abstract available
Early Benralizumab Use for the Successful Treatment of Eosinophilic
Granulomatosis with Polyangiitis-associated Peripheral Neuropathy.
Intern Med. 2026;65:2929-2933.
PubMed
Abstract available
Syphilis infection and autoimmune disease: A matched case-control study with
clinical follow-up in 1,042 patients.
J Autoimmun. 2026;165:103652.
PubMed
Abstract available
The altered T cell landscape in systemic sclerosis patients is characterized by
dysfunctional type 1 immunity.
J Immunol. 2026;215:vkag288.
PubMed
Abstract available
Uncovering disability progression in people with multiple sclerosis: a practical
guide.
J Neurol. 2026;273:699.
PubMed
Abstract available
Diabetic cataract at type 1 diabetes onset: frequency and characteristics.
J Pediatr Endocrinol Metab. 2026;39:1111-1117.
PubMed
Abstract available
Biphasic neonatal Graves disease following maternal thyroidectomy: a case report.
J Pediatr Endocrinol Metab. 2026 Nov 9. doi: 10.1515/jpem-2026-0581.
PubMed
Abstract available
Modified immune cell therapy targets kidney-resident tertiary lymphoid structures
and ameliorates murine lupus nephritis.
Kidney Int. 2026 Nov 5:S0085-2538(26)00910-5. doi: 10.1016/j.kint.2026.
PubMed
Abstract available
Ontogenically distinct macrophages occupy discrete kidney niches and contribute
to monocyte recruitment in experimental crescentic glomerulonephritis.
Kidney Int. 2026 Nov 5:S0085-2538(26)00907-5. doi: 10.1016/j.kint.2026.
PubMed
Abstract available
Pelvic neurology meets multiple sclerosis.
Mult Scler. 2026 Nov 4:13524585261501838. doi: 10.1177/13524585261501838.
PubMed
Lower recorded prevalence of Alzheimer's disease in natalizumab-exposed older
adults with multiple sclerosis: A hypothesis-generating observation.
Mult Scler. 2026 Nov 3:13524585261499995. doi: 10.1177/13524585261499995.
PubMed
Abstract available
Multiple sclerosis relapse redefined: Effect of an MRI-supported relapse
criterion on ublituximab outcomes in the ULTIMATE I and II trials.
Mult Scler. 2026 Nov 3:13524585261499629. doi: 10.1177/13524585261499629.
PubMed
Abstract available
Emergence of natalizumab anti-drug antibodies during extended interval dosing in
a patient with multiple sclerosis: A case report.
Mult Scler. 2026 Nov 2:13524585261500350. doi: 10.1177/13524585261500350.
PubMed
Abstract available
Impact of 2024 Revisions of Multiple Sclerosis Diagnostic Criteria in People With
Radiologically Isolated Syndrome.
Neurology. 2026;107:e218691.
PubMed
Abstract available
Occupational Exposure to Petroleum-Derived Lubricants and Risk of Multiple
Sclerosis.
Neurology. 2026;107:e218718.
PubMed
Abstract available
Toward a Biology-Driven Diagnosis of Multiple Sclerosis: What the 2024 McDonald
Criteria Mean for Radiologically Isolated Syndrome.
Neurology. 2026;107:e218758.
PubMed
Timing Is Everything: Occupational Petrolatum-Based Lubricant Exposure and
Multiple Sclerosis.
Neurology. 2026;107:e218747.
PubMed
USP46 restrains K63-linked polyubiquitination-dependent aggregation and
activation of the NLRP3 inflammasome in lupus nephritis.
Proc Natl Acad Sci U S A. 2026;123:e2601940123.
PubMed
Abstract available
Thank you for your interest in scientific medicine.